Physician profile
Michael G Beardsley
NPI 1477665008
$1,820.54
in general payments reported to CMS, 2019-2025
19 companies · $289 in 2025
The $289 reported for 2025 was more than what 84% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $185 · 2021: $149 · 2022: $221 · 2023: $275 · 2024: $444 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,007.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $369.15 | 2021-2025 | Qelbree, Qelbree |
| Glaxosmithkline, LLC. | $338.62 | 2019-2025 | Bexsero, Fluarix Quadrivalent, Pediarix |
| Cranial Technologies, INC | $309.23 | 2019-2024 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $119.37 | 2019-2022 | |
| Pfizer INC. | $116.74 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $113.94 | 2019-2023 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Sanofi Pasteur INC. | $95.77 | 2020-2025 | |
| Seqirus USA INC | $58.25 | 2022-2025 | Flucelvax |
| Vertical Pharmaceuticals, LLC | $45.99 | 2024 | Relexxii |
| Cognoa, INC. | $43.02 | 2022 | |
| Phadia US INC. | $39.43 | 2024 | Immunocap |
| Corium, LLC | $31.79 | 2025 | Azstarys |
| Abbott Laboratories | $24.63 | 2019 | |
| Sobi, INC | $23.97 | 2019 | |
| Tris Pharma INC | $22.12 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $19.77 | 2024 | Flumist Quadrivalent |
| Lnhc, INC | $19.06 | 2025 | Zelsuvmi |
| Alexion Pharmaceuticals, INC. | $17.22 | 2024 | Koselugo |
| Adlon Therapeutics L.P. | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Beardsley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.